TIRZEPATIDE 60 mg

TIRZEPATIDE 60MG

INSTRUCTIONS FOR USE Step-by-Step Guide

Before you start: Wash your hands thoroughly.

Materials needed:

• Vial of lyophilized Tirzepatide (10 mg)
• Bacteriostatic water (10 ml)
• Insulin syringes (U-100)
• Syringe (5 ml)
• Alcohol wipe

Steps:

Preparing the vials:

• Remove the plastic top from both vials (Tirzepatide and bacteriostatic water). Do not remove the rubber stoppers.
• Disinfect the top of both vials with an alcohol wipe.

Drawing up the bacteriostatic water:

• Take the 5 ml syringe and draw up 2.4 ml of bacteriostatic water.

Dissolving Tirzepatide in bacteriostatic water:

• Hold the Tirzepatide vial horizontally.
• Carefully and slowly, inject the drawn-up bacteriostatic water into the Tirzepatide vial. Note: It is normal for the water to be absorbed quickly by the vial due to the vacuum.

Dissolving:

• Gently roll the vial between your hands to mix the Tirzepatide with the bacteriostatic water.
• Important: Avoid shaking the vial vigorously.
• If preferred, you can let the vial rest for 20 minutes for the Tirzepatide to dissolve completely.

Storage:

• Once dissolved, you can use the Tirzepatide immediately or refrigerate it.
• Never freeze the Tirzepatide vial once diluted.

INJECTING TIRZEPATIDE

Complete dissolution: Ensure that the peptide powder is completely dissolved in the liquid and that there are no lumps.

Dosing Tirzepatide:

• Tirzepatide solution is injected once a week, preferably on the same day each week.

• Starting dose: Generally, start with a dose of 2.5 mg.

• Dose increases: If necessary, the dose can be increased in increments of 2.5 mg each time, as long as there is no significant weight loss over a period of 3-4 weeks and good tolerance is observed.

• Maximum dose: The maximum recommended dose is 15 mg.

• Maintenance: Once the target weight is reached, it is possible to gradually reduce the amount of the doses or space out the frequency of the applications to every 15 days.

DOSING TABLE FOR SUBCUTANEOUS INJECTION
Dose equivalence: To facilitate use, Tirzepatide offers the same effective dose in all its presentations (10mg, 30mg, 60mg), minimizing the risk of errors in injectable dosing.

Important:

Unit of measurement: The amount of tirzepatide to be injected is measured in units using the U-100 insulin syringe, not in milligrams (mg). Follow medical instructions: Always follow your doctor’s instructions regarding the dose and frequency of injections.

Subcutaneous Injection Sites

The injection is administered subcutaneously, that is, under the skin, in areas with fatty tissue such as the thigh, upper arm, or abdomen (approximately five centimeters around the navel). Rotate the injection site each time you inject.

How to administer a subcutaneous injection

1. Gather your supplies: (Tirzepatide vial, insulin syringe, alcohol pad).
2. Wash and dry your hands thoroughly.
3. Insert the needle into the rubber stopper of the vial, turn the vial upside down, and draw up the correct number of units as indicated in the Subcutaneous Injection Dosing Table.
4. Pinch a section of skin between your thumb and index and middle fingers. Make sure you are only pinching skin, not muscle. The skin fold should be firm but not too tight.
5. Push the needle completely into the skin at a 45-degree angle. Press the plunger completely, then release the skin and remove the needle.